2016-03-08T00:00:00.000-05:00
NEXAFED® Sinus,-0.439033
product candidates,-0.467187
opioid release,-0.656216
worldwide exclusive license,0.281499
specialty pharmaceutical company,-0.491916
nasal passages,-0.759241
Ritz-Carlton Laguna Niguel,0.239351
hcl immediate-release tablets,-0.39703
medication abuse,-0.479551
misuse,-0.479551
AVERSION technology,-0.4772
Acura markets NEXAFED®,-0.439033
Dana Point,0.239351
multiple tablets,-0.656216
